Mapping TBI improvement with MAPCs

HOUSTON, TX (December13, 2013)

A preclinical study has revealed that a stem cell treatment known as Multipotent Adult Progenitor Cell therapy is capable of engendering lasting cognitive improvement in rat models of traumatic brain injury. The study, “Intravenous multipotent adult progenitor cell therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury,” was funded by a Small Business Innovation Research agreement with Athersys and grants from Brown Foundation Inc. and Children’s Memorial Hermann Hospital Foundation.

 
View article